fbpx

Clinical Pharmacology

6 09, 2021

Neuropsychiatric Drug Development (NDD)

2020-12-21T22:05:43+00:00September 6th, 2021|

Please join us this year and hear Dr. Zammit present followed by a live Q&A session after on September 8th, 2021. More details to come. The scarcity of new drugs for neuropsychiatric disorders contrasts with the extraordinary advances in neuroscience research to date. Focusing from bench to bedside, and built with thought-leaders at Sage Therapeutics, [...]

8 03, 2021

ASCPT Annual Meeting

2020-12-21T21:54:25+00:00March 8th, 2021|

ASCPT is excited to host a fully online ASCPT 2021 Annual Meeting! Join the global ASCPT community this spring to hear the latest advancements in clinical pharmacology and translational science. Attend dozens of scientific sessions to hear ground-breaking research from the comfort of your own home, including ASCPT’s popular State of the Art lectures, poster [...]

22 02, 2021

ASENT Annual Meeting 2021

2020-12-21T21:50:00+00:00February 22nd, 2021|

The ASENT 2021 Annual Meeting is the only unique forum in American Neurology which brings together divergent areas of effort from industry, academia, advocacy, and government on one platform with open dialogue. We are pleased to welcome our faculty who include executive-level biohealth industry leaders, chairs of neurology and clinician-scientists from leading academic institutions from [...]

6 12, 2020

ACNP Annual Meeting

2020-10-05T16:07:55+00:00December 6th, 2020|

The Annual Meeting is one of the world’s leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs. The Annual Meeting provides an opportunity to: • Attend an outstanding scientific program in clinical and basic research on brain behavior-drug interactions. • Learn about the most recent and often [...]

10 11, 2020

Neuropsychiatric Drug Development (NDD)

2020-11-02T13:59:38+00:00November 10th, 2020|

Please join us at 10:05 am on Wednesday, November 11 to hear Dr. Zammit present “The Role of the CRO in Patient-Centric CNS Clinical Trials” followed by a live Q&A session after. The scarcity of new drugs for neuropsychiatric disorders contrasts with the extraordinary advances in neuroscience research to date. Focusing from bench to bedside, [...]

29 10, 2020

CNS Summit

2020-10-05T15:28:51+00:00October 29th, 2020|

Join the pharma and biotech R&D leaders, the top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and the regulators from FDA and EMA at CNS Summit 2019.   For three days, you’ll experience a dynamic environment for networking and idea-sharing, for learning from industry leaders and exploring the future [...]

9 09, 2020

Free Webinar: Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies

2020-09-03T14:29:56+00:00September 9th, 2020|

Join us to learn more about "Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies". Attendees learn more about the role of translational medicine in a drug development program, preparation of a successful IND package, and preparation for a successful pre-IND meeting. Luana Pesco Koplowitz received her MD from Rutgers Medical [...]

27 08, 2020

APSS/SLEEP 2020

2020-08-12T19:10:15+00:00August 27th, 2020|

SLEEP is the premier world forum for the presentation and discussion of the latest developments in clinical sleep medicine and sleep and circadian science. The SLEEP meeting provides evidence-based education to advance the science and clinical practice of sleep medicine, disseminates cutting-edge sleep and circadian research, promotes the translation of basic science into clinical practice, [...]

2 03, 2020

ASENT Annual Meeting

2020-02-21T22:41:06+00:00March 2nd, 2020|

The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.

19 02, 2020

ISCTM Annual Meeting 2020

2020-01-24T20:17:37+00:00February 19th, 2020|

Recent years have seen a steady increase in the new applications of somatic therapies that target symptom change in interaction with psychotherapeutic interventions. Examples range from use of repetitive transcranial magnetic stimulation combined with symptom provocation for obsessive compulsive disorder, to intranasal oxytocin combined with social cognition training for young people with early psychosis, to [...]